HOME >> MEDICINE >> NEWS
New Inteleos features gives users the ability to tailor information

Amsterdam, December 6, 2006 -- Elsevier, a world-leading healthcare and scientific publisher, announced today new features for its drug tracking and analysis tool, Inteleos. These features enable users to search drug records by Mechanism of Action and Drug Class, graphically chart competitor drugs using a new analysis tool, and search and review clinical trial reports from ClinicalTrials.gov. Users can increase productivity and improve results by specifically tailoring information to meet their business needs.

By indexing Mechanism of Action terms and creating a searchable Drug Class field, Inteleos increases the flexibility of its search and analysis features. The Competitive Grid analysis tool graphically charts competitor drugs per therapy area and allows for comparisons by mechanism of action or drug class, creating dynamic results instantly. Using information reported by ClinicalTrials.gov users can identify and analyze clinical trials across industry, government and academia. Users can also view key trial details specific to drug records.

"Our team continues to show real commitment to customer focus. Improvements made to Inteleos are based on industry feedback; users tell us what they need - the type of information and the format - to improve their business decision-making and we strive to meet these needs" says Julie Gordon, Director of Inteleos, Elsevier. "The inclusion of the Drug Class feature enhances the flexibility and breadth of searching and analysis possible and this is actualized by the Competitor Grid analysis tool. Trial information, via ClinicalTrials.gov, further expands our service into the clinical environment and is the starting point for future enhancements, as customers tell us this is an area of critical need."

In the coming months, Inteleos will enhance services for BizInt customers by enabling the export of Inteleos data into BizInt Smart Charts.


'"/>

Contact: Heleen van Weel
heleen@thereevesagency.com
31-203-051-380
Elsevier
6-Dec-2006


Page: 1

Related medicine news :

1. Emory/Georgia Tech Predictive Health Symposium features national healthcare leaders
2. Post-mortem brain studies reveal features of mild cognitive impairment
3. ARVO annual meeting features over 6,000 presentations
4. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
5. Thymus transplants gives hope to babies with fatal immune disease
6. Plasmonics book gives overview of technology that could revolutionize computing
7. Study of leukemia survivors gives hints for better care
8. Breast cancer treatment procedure gives women more options
9. Woodruff Foundation gives major boost to Emory Universitys strategic plan
10. Core needle biopsy gives an accurate picture of gene expression in whole tumor
11. NICE gives backing for the use of advanced biological therapies to treat severe psoriasis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
Cached News: